Skip to main content
Log in

Differentiation-Dependent Changes in Human Trophoblast Expression of Decay-Accelerating Factor Are Modulated by 3′,5′ Cyclic Adenosine Monophosphate

  • Original Article
  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

Decay-accelerating factor (DAF) is a complement regulatory protein that prevents complement-mediated cell lysis. Its expression in human trophoblasts depends on their anatomic location and gestational age. The mechanisms that govern the regulation of its expression in trophoblasts are not understood. The objective of the present study was to investigate the effects of trophoblast differentiation and cyclic adenosine monophosphate (cAMP) on DAF expression.

Methods

Human trophoblasts were isolated from chorionic villi, cultured, and harvested at timed intervals for total RNA extraction and Northern analysis. Expression of DAF was also assessed by immunocytochemistry. In some cultures, the trophoblasts were exposed to the cAMP agonists 8-bromo-cAMP and Sp-cAMPs or the antagonist Rp-cAMPs.

Results

Expression of DAF mRNA increased as the cells differentiated in culture, with the 2.2-kb transcript of membrane-bound DAF appearing first. As differentiation proceeded, the 1.5-kb transcript became the predominant mRNA form. Exposure of the cells to Rp-cAMPs delayed this process; 8-bromo-cAMP accelerated it. Sp-cAMPs selectively up-regulated the 2.2-kb mRNA transcript. Immunocytochemistry confirmed the effects of differentiation on DAF protein expression.

Conclusion

Expression of DAF in human trophoblasts is dependent on the state of cell differentiation, and cAMP is an intracellular modulator of this process. This effect may be mediated through alternative processing of DAF mRNA in its 3′ UT region, which in turn affects mRNA stability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Benirschke K, Kaufman P. Pathology of the human placenta, 2nd ed. New York; Springer-Verlag, 1990:13–21.

    Book  Google Scholar 

  2. Davies M, Browne CM. Anti-trophoblast antibody responses during normal human pregnancy. J Reprod Immunol 1985;7:285–97.

    Article  CAS  Google Scholar 

  3. Holmes CH, Simpson KL, Wainwnght SD, et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099–105.

    CAS  PubMed  Google Scholar 

  4. Hsi B-L, Hunt JS, Atkinson JP. Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells. J Reprod Immunol 1991;19:209–23.

    Article  CAS  Google Scholar 

  5. Tedesco F, Narchi G, Radillo O, Men S, Ferrone S, Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol 1993;151:1562–70.

    CAS  PubMed  Google Scholar 

  6. Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW, Nussenzweig V. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 1987;325:545–9.

    Article  CAS  Google Scholar 

  7. Nicholson-Weller A, Bürge J, Fearon DT, Weller PF, Austen KF. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 1982;129:184–9.

    CAS  PubMed  Google Scholar 

  8. Cunningham DS, Tichenor JR Jr. Decay-accelerating factor protects human trophoblast from complement-mediated attack. Clin Immunol Immunopathol 1995;74:156–61.

    Article  CAS  Google Scholar 

  9. Holmes CH, Simpson KL, Okada H, et al. Complement regulator)’ proteins at the feto-maternal interface during human placental development: Distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 1992;22:1579–85.

    Article  CAS  Google Scholar 

  10. Nishikon K, Noma J, Hirakawa S, Amano T, Kudo T. The change of membrane complement regulatory protein in chorion of early pregnancy. Clin Immunol Immunopathol 1993;69:167–74.

    Article  Google Scholar 

  11. Hill JA, Melling GC, Johnson PM. Immunohistochemical studies of human uteroplacental tissues from first-trimester spontaneous abortion. Am J Obstet Gynecol 1995;173:90–6.

    Article  CAS  Google Scholar 

  12. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III. Purification, characterization, and in vitro differentiation of cyto-trophoblasts from human term placentae. Endocrinology 1986;118:1567–82.

    Article  CAS  Google Scholar 

  13. Babalola GO, Coutifaris C, Soto EA, Kliman HJ, Shuman H, Strauss JF III. Aggregation of dispersed human cytotrophoblastic cells: Lessons relevant to the morphogenesis of the placenta. Dev Biol 1990;137:100–8.

    Article  CAS  Google Scholar 

  14. Coutifaris C, Babalola GO, Abisogun AO, et al. In vitro systems for the study of human trophoblast implantation. Ann NY Acad Sci 1991;622:191–201.

    Article  CAS  Google Scholar 

  15. Thomas DJ, Lublin DM. Identification of 5’-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. J Immunol 1993;150:151–60.

    CAS  PubMed  Google Scholar 

  16. Kao L-C, Babalola GO, Kopf GS, Coutifans CS, Strauss III JF. Differentiation of human trophoblasts: Structure-function relationships. In: Leung PCK, Hsueh AJW, Friesen HG, eds. Molecular basis of reproductive endocrinology. New York: Spnnger-Verlag, 1993:159–70.

    Chapter  Google Scholar 

  17. Kinoshita T, Medof ME, Silber R, Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 1985;162:75–92.

    Article  CAS  Google Scholar 

  18. Sambrook J, Fritsch EG, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. Plainview, New York: Cold Spring Harbor Laboratory Press, 1989:719–25, 739-52.

    Google Scholar 

  19. Medof ME, Lublin DM, Holers VM, et al. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 1987;84:2007–11.

    Article  CAS  Google Scholar 

  20. Ringler GE, Strauss HI JF. In vitro systems for the study of human placental endocrine function. Endocr Rev 1990;11:105–23.

    Article  CAS  Google Scholar 

  21. Hasty LA, Lambris JD, Lessey 13A, Pruksananonda K, Lyttle CR. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gvnecol 1994;170:168–75.

    Article  CAS  Google Scholar 

  22. Smith CWJ, Patton JG, Nadal-Ginard B. Alternative splicing in the control of gene expression. Annu Rev Genet 1989;23:527–77.

    Article  CAS  Google Scholar 

  23. Maniatis T. Mechanisms of alternative pre-mRNA splicing. Science 1991;251:33–4.

    Article  CAS  Google Scholar 

  24. Erneux C, Van Sande J, Jastorff B, Dumont JE. Modulation of cyclic AMP action in the dog thyroid by its agonist and antagonist Sp- and Rp-adenosine 3’,5’-monophosphorothioate. Bio-chem J 1986;234:193–7.

    CAS  Google Scholar 

  25. Kozak M. Regulation of protein synthesis in virus infected animal cells. Adv Virus Res 1986;31:229–92.

    Article  CAS  Google Scholar 

  26. Brawerman G. Determinants of messenger RNA stability. Cell 1987;48:5–6.

    Article  CAS  Google Scholar 

  27. Gil G, Smith JR, Goldstein JL, Brown MS. Optional exon in the 5’-untranslated region of 3-hydroxy-3-methylglutaryl coenzyme A synthase gene: Conserved sequence and splicing pattern in humans and hamsters. Proc Natl Acad Sci USA 1987;84:1863–6.

    Article  CAS  Google Scholar 

  28. Ladner MB, Martin GA, Noble JA, et al. Human CSF-1: Gene structure and alternative splicing of mRNA precursors. EMBO J 1987;6:2693–8.

    Article  CAS  Google Scholar 

  29. Levy JR, Hannah S, Mooney RL, Hug V, Stevens W. Sequence and functional characterization of the terminal exon of the human insulin receptor gene. Biochim Biophys Acta 1995;1263:253–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Drs. Zarkadis and Omigbodun contributed equally to the work reported in this manuscript.

This study was supported by National Institutes of Health grants HD-30475 (CC), HD-06724 (CC), and AI-30040 (JDL), and by the Rockefeller Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zarkadis, I.K., Omigbodun, A., Forson, A. et al. Differentiation-Dependent Changes in Human Trophoblast Expression of Decay-Accelerating Factor Are Modulated by 3′,5′ Cyclic Adenosine Monophosphate. Reprod. Sci. 4, 47–53 (1997). https://doi.org/10.1016/S1071-5576(96)00061-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-5576(96)00061-5

Key words

Navigation